Paul Sweetnam
CHIEF SCIENTIFIC OFFICER · 1 filing · Latest: Oct 13, 2026
Retension Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
CHIEF SCIENTIFIC OFFICER · 1 filing · Latest: Oct 13, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|